3.65
3.95%
-0.15
Dopo l'orario di chiusura:
3.74
0.09
+2.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.80
Aprire:
$3.74
Volume 24 ore:
343.62K
Relative Volume:
0.92
Capitalizzazione di mercato:
$275.34M
Reddito:
$83.57M
Utile/perdita netta:
$-4.94M
Rapporto P/E:
-40.56
EPS:
-0.09
Flusso di cassa netto:
$6.97M
1 W Prestazione:
-2.41%
1M Prestazione:
+5.80%
6M Prestazione:
+4.89%
1 anno Prestazione:
+150.00%
Chromadex Corp Stock (CDXC) Company Profile
Nome
Chromadex Corp
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
2022-03-08 | Iniziato | ROTH Capital | Buy |
2019-10-16 | Iniziato | Oppenheimer | Outperform |
2019-02-14 | Iniziato | B. Riley FBR | Buy |
2017-11-27 | Ripresa | H.C. Wainwright | Buy |
2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Chromadex Corp Borsa (CDXC) Ultime notizie
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - MSN
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - The Bakersfield Californian
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - StockTitan
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Two Polish men extradited to NI jailed for drugs offences - Ireland Live
A new experience centre in Bengaluru decodes whisky, gin, and heritage brews of India - Condé Nast Traveller India
Nu Republic launches Cyberstud X2 and Cyberstud X4 Firefly TWS in India - Techlomedia
XLRI JAMSHEDPUR’S PRODZION CLUB HOSTS ITS SECOND PRODUCT SYMPOSIUM: AURORA 2.0 - India Education Diary
Jharkhand News: XLRI Jamshedpur hosts product symposium Aurora - The Jharkhand Story
NI Courts Service awards £85M contract to Canadian IT firm CGI - Belfast Live
Nu Republic Unveils Cyberstud X2 and X4 Firefly Wireless Earbuds - Gadget Bridge
BMS alum Catherine Owen Adams to lead Acadia - BioCentury
Firm appointed on £85m contract to modernise courts system in NI - Belfast Telegraph
'Our NI team is proud to contribute to a program that will impact the present and lay foundation for future innovation' - Belfast News Letter
Check Out Chromadex Corp (CDXC)’s Trade Data Rather Than the Analysts’ Views - SETE News
Northern Ireland courts to receive major IT upgrade - Irish Legal News
Delhi HC upholds Penalty on Custodian for Import of Branded Liquor in Addition to Declared Goods - taxscan.in
ChromaDex appoints new CFO Ozan Pamir - Investing.com
ChromaDex appoints new CFO Ozan Pamir - Investing.com India
County Derry man who operated illegal television streaming service for be sentenced next month - Derry Now
ChromaDex appoints new CFO Ozan Pamir By Investing.com - Investing.com Australia
ChromaDex appoints new CFO Ozan Pamir By Investing.com - Investing.com Canada
ChromaDex Appoints Ozan Pamir As Chief Financial Officer - citybiz
ChromaDex Appoints Ozan Pamir as Chief Financial Officer - StockTitan
Pregabalin: Judge calls for longer drug supply jail terms - BBC.com
'Ludicrous': Derry judge critical of maximum sentence available in wake of case linked to drugs death - Derry Journal
Diageo India opens craft experience home - The Spirits Business
BJP Leader Acquitted in Decade-Old Election Code Case - Town Post
Acer Nitro V 16 AMD Ryzen 7-8845HS NVIDIA GeForce RTX 4060 16GB 1TB SSD - Indiatimes
WINTON GROUP Ltd Invests $597,000 in ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Stock Price Passes Above Two Hundred Day Moving Average of $3.06 - MarketBeat
Wells Pharma to distribute Niagen IV to new clinics By Investing.com - Investing.com Australia
Wells Pharma to distribute Niagen IV to new clinics - Investing.com India
Wells Pharma to distribute Niagen IV to new clinics - Investing.com
Wells Pharma to distribute Niagen IV to new clinics By Investing.com - Investing.com Canada
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics - Morningstar
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics - StockTitan
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions - Business Wire
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions - StockTitan
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200 Day Moving Average of $2.99 - MarketBeat
Top investors say Chromadex Corp (CDXC) ticks everything they need - SETE News
Is Chromadex Corp (CDXC) worth investing in despite its undervalued state? - US Post News
ChromaDex Co. (NASDAQ:CDXC) Director Kristin Patrick Sells 23,000 Shares - Defense World
ChromaDex Co. (NASDAQ:CDXC) Director Kristin Patrick Sells 23,000 Shares - MarketBeat
Chromadex director Kristin Patrick sells $82,110 in company stock - Investing.com
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 - StockTitan
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - Manchestertimes
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - StockTitan
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - Yahoo Finance
Chromadex Corp Azioni (CDXC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):